EP 1042347 A1 20001011 - DNA PHARMACEUTICAL FORMULATIONS COMPRISING CITRATE OR A COMBINATION OF CITRATE AND TRIETHANOLAMINE
Title (en)
DNA PHARMACEUTICAL FORMULATIONS COMPRISING CITRATE OR A COMBINATION OF CITRATE AND TRIETHANOLAMINE
Title (de)
PHARMAZEUTISCHE DNS-FORMULIERUNGEN, DIE CITRAT ODER EINE KOMBINATION AUS CITRAT UND TRIETHANOLAMIN ENTHALTEN
Title (fr)
FORMULATIONS PHARMACEUTIQUES D'ADN COMPORTANT DU CITRATE OU UNE COMBINAISON DU CITRATE ET DE LA TRIETHANOLAMINE
Publication
Application
Priority
- GB 9801099 A 19980120
- US 9827310 W 19981222
- US 6872197 P 19971223
Abstract (en)
[origin: WO9932503A1] The present invention relates to nucleic acid formulations of pharmaceutical products which comprise citrate and/or triethanolamine in concentrations which enhance stability of the nucleic acid. These formulations are suited for situations where prolonged storage occurs during the distribution and/or storage period prior to use.
IPC 1-7
IPC 8 full level
A61K 31/7088 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2006.01); A61K 48/00 (2006.01); A61K 47/02 (2006.01)
CPC (source: EP)
A61K 47/12 (2013.01); A61K 48/00 (2013.01); A61K 47/02 (2013.01); A61K 47/18 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 9932503 A1 19990701; AU 1940599 A 19990712; CA 2315032 A1 19990701; EP 1042347 A1 20001011; EP 1042347 A4 20050216; JP 2001526292 A 20011218
DOCDB simple family (application)
US 9827310 W 19981222; AU 1940599 A 19981222; CA 2315032 A 19981222; EP 98964228 A 19981222; JP 2000525440 A 19981222